Generali Investments Management Co LLC Sells 1,700 Shares of Stryker Corporation $SYK

Generali Investments Management Co LLC decreased its position in shares of Stryker Corporation (NYSE:SYK) by 15.7% in the 3rd quarter, Holdings Channel reports. The firm owned 9,122 shares of the medical technology company’s stock after selling 1,700 shares during the quarter. Stryker accounts for about 0.7% of Generali Investments Management Co LLC’s portfolio, making the stock its 27th largest holding. Generali Investments Management Co LLC’s holdings in Stryker were worth $3,372,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Brighton Jones LLC increased its stake in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after acquiring an additional 609 shares in the last quarter. Schnieders Capital Management LLC. bought a new position in Stryker in the 2nd quarter valued at about $205,000. Daymark Wealth Partners LLC lifted its holdings in shares of Stryker by 7.4% in the second quarter. Daymark Wealth Partners LLC now owns 7,306 shares of the medical technology company’s stock valued at $2,890,000 after purchasing an additional 501 shares in the last quarter. Arkadios Wealth Advisors boosted its holdings in Stryker by 17.2% during the 2nd quarter. Arkadios Wealth Advisors now owns 4,747 shares of the medical technology company’s stock worth $1,878,000 after acquiring an additional 695 shares during the last quarter. Finally, Premier Path Wealth Partners LLC boosted its holdings in Stryker by 4.4% during the second quarter. Premier Path Wealth Partners LLC now owns 1,746 shares of the medical technology company’s stock worth $691,000 after purchasing an additional 73 shares during the last quarter. Institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director directly owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 5.90% of the company’s stock.

Stryker Stock Up 0.5%

Shares of NYSE SYK opened at $386.04 on Friday. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. Stryker Corporation has a 12 month low of $329.16 and a 12 month high of $404.87. The firm has a fifty day simple moving average of $362.53 and a two-hundred day simple moving average of $369.14. The firm has a market capitalization of $147.73 billion, a PE ratio of 45.96, a price-to-earnings-growth ratio of 2.24 and a beta of 0.87.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The firm had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. During the same quarter in the prior year, the business earned $4.01 EPS. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. Equities analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is 41.90%.

Analyst Upgrades and Downgrades

SYK has been the subject of several research reports. The Goldman Sachs Group set a $399.00 price target on shares of Stryker in a research report on Friday, January 9th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a research note on Monday, December 22nd. Evercore set a $390.00 price target on Stryker in a report on Monday, January 5th. Needham & Company LLC lifted their price objective on shares of Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Finally, TD Cowen lowered Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price for the company. in a research note on Monday, January 26th. Thirteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and an average target price of $426.47.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.